REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/09/2025
Back to search
Official data from USPTO
CODEXIS PROTEIN ENGINEERING EXPERTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
06/10/2025
Classification
Registered
Trademark type
Combined
Nice classes
1, 40, 42
Filing date
12/04/2017
Registration date
06/09/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/09/2020
Last transaction
06/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2018-02-00
First use in commerce
2018-02-00
Drawing code
5
Owner type
03
Owner location
Redwood City, CA
Examiner
FICKES, JERI
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized word "CODEXIS" in which the letter "X" appears as two strands of DNA. Under the word "CODEXIS" are the words "PROTEIN ENGINEERING EXPERTS".
Holders and representatives
Holders
Codexis, Inc.
Representatives
GABRIELLE S. ROTH SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 1Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemicals for use in research in industry and science; chemicals for use in the manufacture of products for commercial applications pertaining to chemistrypharmaceuticalsmedicine; chemicals and biochemicals for in vitro scientific and research use; chemicals and biochemicals for use in the manufacture of products for commercial use; enzymes used to produce chemicals for research; enzymes used to produce chemicals for use in the manufacture of products for commercial applications pertaining to chemistrypharmaceuticalsmedicine; chemicals and biochemicals for use in the synthesis of pharmaceuticals and chemicals; chemical and biochemical catalysts for use in pharmaceutical and chemical production
Class 40
biomanufacturing in the nature of directed evolution servicesrecombination of genesproteins and enzymes for the benefit of others to produce novel gene sequencesproteins and enzymes for use in scientific and medical researchindustrial and commercial applications in the fields of chemistrypharmaceuticalsbiotherapeuticsfood and beverages; manufacture of chemicals for others
Class 42
biochemistry research and product development for otherscustom design and development of highly optimized proteins and enzymes for use in the fields of scientific and medical researchindustry and commercial applications; chemical research services; scientific research services; researchproduct developmentrelated process development services for others in the fields of chemistrypharmaceuticalsbiotherapeuticsfood and beverages
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/09/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/06/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/05/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/30/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/30/2020
IUAF
USE AMENDMENT FILED
04/15/2020
EISU
TEAS STATEMENT OF USE RECEIVED
04/15/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/06/2019
EX2G
SOU EXTENSION 2 GRANTED
12/04/2019
EXT2
SOU EXTENSION 2 FILED
12/04/2019
EEXT
SOU TEAS EXTENSION RECEIVED
12/04/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/17/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/31/2019
EX1G
SOU EXTENSION 1 GRANTED
05/29/2019
EXT1
SOU EXTENSION 1 FILED
05/29/2019
EEXT
SOU TEAS EXTENSION RECEIVED
05/29/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/04/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/09/2018
PUBO
PUBLISHED FOR OPPOSITION
10/09/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/22/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
08/22/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/22/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
08/22/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/22/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/23/2018
GNRT
NON-FINAL ACTION E-MAILED
03/23/2018
CNRT
NON-FINAL ACTION WRITTEN
03/23/2018
DOCK
ASSIGNED TO EXAMINER
03/16/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/13/2017
NWAP
NEW APPLICATION ENTERED
12/07/2017
Continuous trademark protection
Get notified about every new filing that threatens CODEXIS PROTEIN ENGINEERING EXPERTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.